Prev Arrow Stocks

Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 3.8% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Aurora Cannabis Inc.?

Aurora Cannabis Inc. (ACB) is a Canadian company specializing in the production and distribution of medical cannabis products. The stock had a bullish movement today amidst recent developments in its cannabis cultivars and upcoming investor conference call.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 3.8% on May 20, 2026 14:51

  • The bullish movement in ACB stock could be attributed to the news of being granted Plant Breeders' Rights for its two proprietary cannabis cultivars, Farm Gas and Driftwood Diesel. This recognition not only strengthens Aurora's position in the cannabis market but also highlights its commitment to innovation and product development.
  • The upcoming investor conference call for its fourth quarter and fiscal year 2025 results might have generated positive investor sentiment, leading to increased buying activity and driving the stock price higher.
  • Despite the recent underperformance and consecutive days of losses, the positive news surrounding Aurora Cannabis Inc.'s advancements in cannabis science and intellectual property rights seem to have reversed the downward trend and instilled confidence in investors.

ACB Price Chart

ACB Technical Analysis

ACB News

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

Aurora Cannabis Inc. announced its plan to host an investor conference call for its fourth quarter and fiscal year 2025 results. The company will also file related year-end information. This announcement was delivered via Quantisnow, a real-time market data and news platform.

https://www.quantisnow.com/insight/aurora-cannabis-to-host-fourth-quarter-and-fiscal-year-2025-6069989

0 Missing News Article Image Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

Aurora Cannabis Inc. stock falls Monday, underperforms market

Aurora Cannabis Inc. (ACB) shares fell 1.20% on Monday, closing at $3.28. This performance was amidst a mixed trading session for the broader market, with the Dow Jones Industrial Average rising and the NASDAQ Composite Index falling. This marks the second consecutive day of losses for the stock.

https://www.marketwatch.com/data-news/aurora-cannabis-inc-stock-falls-monday-underperforms-market-d15b2f3a-8f715bf561b0?mod=mw_quote_news

1 News Article Image Aurora Cannabis Inc. stock falls Monday, underperforms market

Number of shareholders of Aurora Cannabis Inc. – DUS:21P

This article states the topic is the number of shareholders for Aurora Cannabis Inc. (DUS:21P) but provides no content regarding the actual number of shareholders, only navigational and copyright information. It appears to be an empty placeholder page within a financial data platform.

https://www.tradingview.com/symbols/DUS-21P/financials-statistics-and-ratios/number-of-shareholders/

2 News Article Image Number of shareholders of Aurora Cannabis Inc. – DUS:21P

Aurora Cannabis Granted Plant Breeders' Rights for Two Cultivars

Aurora Cannabis has been granted Plant Breeders' Rights in Canada for two of its proprietary cannabis cultivars, Farm Gas and Driftwood Diesel. This certification provides Aurora with exclusive rights to cultivate, propagate, and sell products from these varieties. The rights acknowledge Aurora's science-driven approach to developing consistent and reliable medical cannabis cultivars for patients globally.

https://www.cannabisequipmentnews.com/cultivation/news/22966928/aurora-cannabis-granted-plant-breeders-rights-for-two-cultivars

3 Missing News Article Image Aurora Cannabis Granted Plant Breeders' Rights for Two Cultivars

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science

Aurora Cannabis Inc. has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars, Farm Gas™ and Driftwood Diesel™. This recognition, similar to patents, gives Aurora exclusive rights to grow, propagate, and sell products from these varieties. The certification protects Aurora's significant investment in its advanced research and breeding program, underscoring its science-driven approach to developing consistent and reliable medical cannabis products for global markets.

https://www.prnewswire.com/news-releases/aurora-granted-plant-breeders-rights-strengthening-leadership-in-cannabis-science-302771046.html

4 News Article Image Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science

Aurora Cannabis Inc. Price History

22.03.2026 - ACB Stock was up 6.5%

  • Following a period of market underperformance, ACB demonstrated a notable bullish movement today.
  • The acquisition of Safari Flower Company for $26.5 million appears to have boosted investor confidence in Aurora Cannabis.
  • This strategic acquisition is anticipated to strengthen Aurora's presence in the premium cannabis sector and bolster its global market position, potentially fueling a positive trend in the stock.
  • Analysts hold differing views on Aurora's financial status and growth potential, but the recent acquisition highlights the company's proactive efforts to expand its market share and product line.

05.02.2026 - ACB Stock was down 5.4%

  • The recent decline in ACB's stock price may be linked to the company's shift away from lower-margin Canadian consumer markets in favor of medical cannabis operations.
  • Investors are anxious about potential short-term financial effects as Aurora Cannabis makes this transition, prompting them to sell off the stock.
  • Despite positive analyst outlooks and a "Buy" rating suggesting a 66% upside, market sentiment is cautious as the company undergoes this strategic change, potentially leading to stock price fluctuations.
  • Targeting lucrative international medical markets such as Germany and Australia, though promising for future growth, is generating uncertainty among investors in the immediate term, contributing to the stock's recent bearish trend.

20.02.2026 - ACB Stock was down 5.1%

  • The stock of Aurora Cannabis Inc. (ACB) experienced a bearish movement today, declining by 1.98% amidst a challenging trading session for the overall market.
  • The initiation of coverage on ACB with a speculative buy rating and a price target of C$10 did not seem to have a positive impact on the stock's performance.
  • The previous day's rise in ACB stock price was not sustained, indicating a potential reversal in investor sentiment.
  • The analysis highlighted weak near and long-term ratings, suggesting that investors may have been cautious about the stock's future performance, contributing to the bearish movement.

30.03.2026 - ACB Stock was up 5.1%

  • Despite recent underperformance in the market, Aurora Cannabis saw a bullish movement today, potentially driven by its strategic expansion of high-potency medical cannabis products in key international markets.
  • The projected significant growth in the U.S. cannabis market could have positively influenced investor sentiment towards Aurora Cannabis, as the company positions itself to capitalize on the expanding industry.
  • Aurora Cannabis' focus on precision, diversification, and regulatory compliance in its product launches aligns well with the evolving trends in the medical cannabis sector, indicating a strategic advantage for the company.
  • The improving operational trajectories and constructive earnings outlook, coupled with the company's expansion efforts, may have contributed to the bullish movement in Aurora Cannabis stock today.

25.02.2026 - ACB Stock was up 6.1%

  • Aurora Cannabis Inc. (ACB) witnessed a 1.53% increase in its stock price today, breaking a previous downtrend, despite sector challenges.
  • XETRA's pre-market trading indicated a 2.86% decrease, attributed to sector weaknesses and high inventory levels, highlighting the company's ongoing struggles.
  • Despite recently hitting a new 52-week low, analysts maintain a "Buy" consensus with a target price of C$9.25, reflecting differing opinions on the company's future.
  • The stock's performance diverged from the broader market today, showcasing better performance during a positive trading session, indicating potential volatility and uncertainty in the cannabis sector.

23.03.2026 - ACB Stock was down 5.2%

  • ACB stock displayed a significant downward movement today, contrasting with its recent positive showings.
  • The acquisition of Safari Flower Company for C$26.5 million likely initially boosted investor confidence, contributing to the recent uptrend.
  • Nevertheless, factors such as market volatility and broader economic conditions could have played a role in today's bearish movement, overshadowing the positive impact of the acquisition.
  • Investor sentiment might have been influenced by uncertainties in the cannabis sector or profit-taking activities following recent gains, resulting in underperformance of the stock compared to the overall market today.

14.03.2026 - ACB Stock was up 5.8%

  • ACB stock saw a 1.5% increase, amid diverse analyst outlooks and recent underperformance on quarterly financial projections.
  • Traders on TradingView provided technical analyses pointing towards an optimistic future for ACB, highlighting key levels of resistance and support, chart configurations, and risk mitigation approaches.
  • Despite trading below its highest point in a year, ACB demonstrated strength in today's market, underscoring its resilience in a volatile sector.
  • With consecutive days of growth, ACB's upward trajectory signals growing positivity and investor engagement, buoying the stock price increase.

13.03.2026 - ACB Stock was up 5.2%

  • The bullish movement in ACB today can be attributed to a combination of technical factors and market sentiment:
  • Despite recent underperformance compared to the broader market, multiple traders on TradingView have identified bullish patterns like inverse head and shoulders, bull pennants, and symmetrical triangles, signaling a potential upward trend.
  • The consecutive days of gains on Thursday and Wednesday, even though underperforming the market, have likely contributed to renewed investor confidence in ACB.
  • The technical analysis, despite assigning a low rating, notes a decent setup pattern and reduced volatility, which might have attracted traders looking for short-term opportunities in a volatile market.

31.02.2026 - ACB Stock was up 5.1%

  • The bullish movement in Aurora Cannabis Inc. (ACB) today could be attributed to:
  • The company's recognition for gender diversity on its leadership team, highlighting its commitment to inclusivity and talent development.
  • Positive financial performance, potentially indicated by strong cash from operating activities, which may have instilled confidence in investors.
  • Despite recent market downturns, Aurora Cannabis Inc. managed to outperform the broader market, showcasing resilience and potential strength in its operations.
  • The consecutive days of stock increases could be a result of strategic decisions or market sentiment favoring the company's position in the medical cannabis industry.

03.02.2026 - ACB Stock was down 5.3%

  • Investors may question the growth potential of Aurora Cannabis in the recreational cannabis market as the company shifts exclusively to medical cannabis and targets regulated international markets.
  • The strategic shift, including reducing focus on the Canadian consumer business and expanding GMP manufacturing, could be seen as a defensive response to industry challenges, leading to a negative sentiment among traders.
  • Despite analysts predicting a potential 66.60% upside for ACB stock, doubts remain about the company's ability to leverage future market trends given concerns about its track record, net losses, and limited presence in the U.S. market.
  • Market insights and trading signals suggesting a weak long-term rating for ACB:CA align with the observed bearish movement, reflecting a lack of confidence in the company's future growth prospects.

29.03.2026 - ACB Stock was down 5.2%

  • The recent bearish movement in ACB stock could be linked to profit-taking following a two-day winning streak, with investors possibly aiming to secure their profits.
  • Despite expanding its global medical cannabis product line, concerns regarding the company's weak cash-flow quality and poor technical momentum may have impacted market sentiment.
  • While the U.S. cannabis market shows promising growth prospects, regulatory uncertainty and intensifying competition within the industry may be influencing the cautious outlook on Aurora Cannabis.
  • Investors might be holding off on full commitment to the stock until seeing more concrete results from its strategic initiatives, potentially contributing to the observed bearish movement today.

20.04.2026 - ACB Stock was up 3.8%

  • The bullish movement in ACB stock could be attributed to the news of being granted Plant Breeders' Rights for its two proprietary cannabis cultivars, Farm Gas and Driftwood Diesel. This recognition not only strengthens Aurora's position in the cannabis market but also highlights its commitment to innovation and product development.
  • The upcoming investor conference call for its fourth quarter and fiscal year 2025 results might have generated positive investor sentiment, leading to increased buying activity and driving the stock price higher.
  • Despite the recent underperformance and consecutive days of losses, the positive news surrounding Aurora Cannabis Inc.'s advancements in cannabis science and intellectual property rights seem to have reversed the downward trend and instilled confidence in investors.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.